If a person is taking semaglutide alongside diuretics, the combined effect might result in more frequent urination than expected
Boehringer Ingelheim announced positive Phase III results for survodutide, a glucagon/GLP-1 dual agonist, showing weight loss and metabolic improvement in obesity and overweight populations, while also building evidence in MASLD-related metabolic disease
In many cases, medication optimization happens gradually, with reductions initiated only after confirmed sustained blood pressure improvement and resolution of any hypertensive medications' original indication
It may cause the body to lose too much water
However, if it makes you drowsy, your doctor might suggest taking it at bedtime
Mike Reinold: Thats what they always say